PIK3CA and pachyonychia congenita: The current data, together with other studies are not demonstrating the involvement of PIK3CA mutation in PC, however, other components of the PI3K pathway in these tumors may be involved in PC tumorigenesis and suggest that the PI3K pathway may exhibit a valuable target for the development of novel therapies for this type of cancer.